LPL Financial’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.58M Sell
175,231
-120,975
-41% -$1.91M ﹤0.01% 3725
2025
Q4
$5.4M Buy
296,206
+93,425
+46% +$1.57M ﹤0.01% 2470
2025
Q3
$2.97M Sell
202,781
-12,401
-6% -$213K ﹤0.01% 2956
2025
Q2
$3.92M Buy
215,182
+104,929
+95% +$2.14M ﹤0.01% 2511
2025
Q1
$2.19M Buy
110,253
+50,565
+85% +$874K ﹤0.01% 2878
2024
Q4
$1.02M Sell
59,688
-521
-0.9% -$9.8K ﹤0.01% 3465
2024
Q3
$1.2M Buy
60,209
+10,663
+22% +$166K ﹤0.01% 3212
2024
Q2
$554K Buy
49,546
+32,982
+199% +$277K ﹤0.01% 3792
2024
Q1
$109K Buy
16,564
+4,620
+39% +$25.3K ﹤0.01% 4662
2023
Q4
$54K Buy
11,944
+71
+0.6% +$263 ﹤0.01% 4644
2023
Q3
$42.5K Buy
11,873
+637
+6% +$2.45K ﹤0.01% 4536
2023
Q2
$41.5K Sell
11,236
-11,657
-51% -$43.2K ﹤0.01% 4443
2023
Q1
$75.8K Buy
22,893
+1,773
+8% +$6.13K ﹤0.01% 4253
2022
Q4
$81.9K Buy
+21,120
New +$65.1K ﹤0.01% 4208

Other funds holding ADMA